Back to ENTA

Spruce Street Capital LP → ENTA

Spruce Street Capital LP ENTA Position History

Enanta Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$14.3M
Q3 2026
Peak value
$15.9M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.1M
Q1 2026$11.8M
Q2 2026$15.9M
Q3 2026$14.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$14.3M1.09M——
Q2 2026$15.9M1.09M——
Q1 2026$11.8M932.6K——
Q4 2025$6.1M389.7K——

Other funds holding ENTA

Other Spruce Street Capital LP positions

KNSA

KINIKSA PHARMACEUTICALS INTL

$68.5M
KNSA

KINIKSA PHARMACEUTICALS INTL

$58.7M
RLAY

RELAY THERAPEUTICS INC

$55.8M
RLAY

RELAY THERAPEUTICS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$44.7M
RLMD

RELMADA THERAPEUTICS INC

$44.2M
RLMD

RELMADA THERAPEUTICS INC

$43M